MPLBind: Predicting the Effect of Binding Site Point Mutations on Protein–Ligand Binding Affinity Using Protein Large Language Models
Journal of Chemical Information and Modeling · 25.08.2025 · 65 (16) · 8720-8729
DOI: 10.1021/acs.jcim.5c00838 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Chemical Information and Modeling, online erschienen am 07.08.2025. Verfasst von Jiahuan Jin und 1 weiteren Autor:innen. Beteiligte Einrichtung: Research Center of Bioinformatics, School of Computer Science and Technology, Harbin Institute of Technology, Harbin, Heilongjiang 150001, China. Hauptthemen laut MEDLINE: Point Mutation, Proteins, Computational Biology. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 41 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Research Center of Bioinformatics, School of Computer Science and Technology, Harbin Institute of Technology, Harbin, Heilongjiang 150001, China.
ORCID-Profile: Jie Li
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Jin, J., & Li, J. (2025). MPLBind: Predicting the Effect of Binding Site Point Mutations on Protein–Ligand Binding Affinity Using Protein Large Language Models. Journal of Chemical Information and Modeling, 65(16), 8720-8729. https://doi.org/10.1021/acs.jcim.5c00838
Vancouver
Jin J, Li J. MPLBind: Predicting the Effect of Binding Site Point Mutations on Protein–Ligand Binding Affinity Using Protein Large Language Models. Journal of Chemical Information and Modeling. 2025;65(16):8720-8729. doi:10.1021/acs.jcim.5c00838
BibTeX
@article{Jin2025,
author = {Jin, Jiahuan and Li, Jie},
title = {MPLBind: Predicting the Effect of Binding Site Point Mutations on Protein–Ligand Binding Affinity Using Protein Large Language Models},
journal = {Journal of Chemical Information and Modeling},
year = {2025},
volume = {65},
number = {16},
pages = {8720--8729},
doi = {10.1021/acs.jcim.5c00838}
}
EUVIMED